Five Hot Tips – Private Businesses

Five Hot Tips – Private Businesses

In contrast, given investors the Council that at least for now stay away from Cloetta, Bactiguard and TradeDoubler.

The journey of automotive safety company Autoliv has just begun, despite a phenomenal journey in recent years. A market leading position, increasing market share, are strong and good cost speaks to the company’s favor.

In terms of p / e ratio measured Autoliv in line with the stock market as a whole and in the short term, the potential is limited, but in a years ahead, a “continued solid operating performance and a stock that can continue to perform,” writes Börsveckan, which therefore reiterates its buy recommendation.

Defence group Saab has reason to look forward to better market conditions ahead. The company is trimmed after years of lower defense spending and Kockums acquisition opens new doors. The valuation is remarkable given the stable order book, says BV and recommend the purchase.

The pulp mill Rottneros hefty tailwind thanks to high pulp prices and rising dollar. Add to that significant efficiency improvements and the last year’s big price increase becomes explicable. A resumption of dividend suggests self-confidence, writes Börsveckan, which again gives the Council the purchase.

Staffing Company SJR may be repeated buying advice, despite an expected slower profit growth. The high dividend represents a cushion on the downside and Börsveckan see a total potential of 20 percent on the upside.

Even Beijer Electronics looks bright, since the IDC business area has gone from strength to strength. The Board is investing in the area and when the wager impact expected positive effects. With an improved economy, there is scope for a significant earnings improvement, consider Börsveckan who think that the share is exciting for the last year’s slump.

confectionary manufacturer Cloetta see it more acidic out. The Company has not met the market’s high expectations and it is doubtful that profitability should be increased further in line with consensus forecasts, according to the newspaper and gives the Council await.

Nor medical technology company Bactiguard fall BV on the lip. Despite a weak performance in the stock market is not buying opportunity. Sales fell sharply in the fourth quarter and operating profit turned to loss. If any result is even worse than it looks at first glance, claims the newspaper and discourages purchase.

Even Tradedoubler still struggling in the fierce headwind. Last year ended with a hefty loss and the long-awaited turnaround seems to linger. The risks outweigh the still and share attracts not, despite negative price developments of 20 percent since the last report. Wait, says Börsveckan.